Vistin Pharma ASA (OSL:VISTN)

Market Cap	1.06B
Revenue (ttm)	440.66M
Net Income (ttm)	76.79M
Shares Out	44.34M
EPS (ttm)	1.73
PE Ratio	13.80
Forward PE	n/a
Dividend	1.25 (5.23%)
Ex-Dividend Date	Jun 4, 2025

Volume	83,703
Average Volume	22,322
Open	24.30
Previous Close	24.70
Day's Range	23.60 - 24.30
52-Week Range	20.70 - 28.80
Beta	0.72
RSI	42.51
Earnings Date	Aug 15, 2025

About Vistin Pharma ASA

Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, engages in the production and sale of active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is based in Oslo, Norway.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1969
• Employees: 75
• Stock Exchange: Oslo Børs
• Ticker Symbol: VISTN

Financial Performance

In 2024, Vistin Pharma ASA's revenue was 429.50 million, a decrease of -2.01% compared to the previous year's 438.33 million. Earnings were 62.75 million, an increase of 37.62%.